Compounding Defense Initiative
In 2026, APC, state associations, pharmacists, patients, and other advocates stopped or mitigated major legislative threats to pharmacy compounding in 10 states. For 2027, APC anticipates similar proposals in as many as 25 states, plus at least two bills moving through Congress.
What you can do
These drugmaker proposals do not target real concerns that have arisen from the era of GLP-1s. APC proposes five practical reforms aimed at real concerns. Many of these solutions could be pursued at either the federal or state level. These are common-sense solutions that actually enhance patient safety.
More information
Questions about these reforms?
Reach out to Tenille Davis, PharmD or another member of the APC team for more information.
Require clear disclosure on medication labeling that compounded medications are not FDA-approved.
Require 503A pharmacies to report serious adverse events via FDA’s MedWatch system.
Prohibit direct-to-consumer marketing of substances that cannot lawfully be compounded for human use. For instance, research-grade ingredients are illegal for use in human drugs. Marketing them to consumers should be, too.
Close oversight gaps involving medical spas and similar businesses at the state level, where they should be regulated.
Protect lawful pharmacies from deceptive legal intimidation by drugmakers.
APC needs your help
Pharmacists like you can help policymakers understand what pharmacy compounding actually looks like in local communities. Your stories can show lawmakers that compounding is a regulated, patient-specific practice, and that restrictions that may sound reasonable on paper can create real barriers to patient care.
Priority legislator list
APC has identified a menu of priority legislators most likely to have a voice on compounding legislation in states where harmful bills could be introduced. Reach out to Tenille Davis, PharmD or another member of the APC team for more information.
Before a drugmaker-backed bill ever lands on their desk, get to know your state legislators.
These legislators need to know about the importance of compounding to patient care. There’s no better way to learn than to hear from you!
Show them what pharmacy compounding, patient care, quality standards, and compliance look like in action.
Take action
The 2026 results proved that early action works. With a broader wave of restrictive legislation expected in 2027, APC’s Compounding Defense Initiative needs to raise critical funds by December 31 to prepare and respond before threats gain momentum.
Help defend patient access in 2027. Support the Compounding Defense Fund.
.png?width=17&height=16&name=folder%20(1).png){kind=small}
